The Dilon Advantage: A Clear Diagnosis
The Dilon 6800 Gamma Camera is optimized to perform BSGI and provide detection of small lesions, providing a vital diagnostic adjunct to mammography and ultrasound.
What is BSGI?
Breast-Specific Gamma Imaging (BSGI) is a molecular breast imaging procedure that shows the metabolic activity of breast lesions. The Dilon 6800 Gamma Camera is optimized to reveal images that help doctors manage difficult to diagnose cases.
BSGI has been performed on more than 80,000 patients in both hospitals and private imaging centers across the country.
A small amount of tracing agent is delivered to the patient, and is absorbed by all cells in the body. The tracing agent emits invisible gamma rays, which are detected by the Dilon 6800 and translated into a digital image of the breast. Due to the higher metabolic activity of cancerous cells, these cells absorb a greater amount of the tracing agent and are revealed as "dark spots."
Other tests, such mammography and ultrasound, image the physical structure of the breast. BSGI captures the actual cellular function of the breast tissue.
BSGI is a valuable tool following a questionable mammogram, when further evaluation is needed. Especially when patients have:
dense breast tissue
multiple indeterminate or suspicious lesions or clusters of microcalcifications
lesions that can be felt, but not detected with mammography or ultrasound
post-surgical or post-therapeutic densities
been taking Hormone Replacement Therapy
The Dilon 6800 Gamma Camera
BSGI is made possible by the Dilon 6800, a leading edge, high-resolution camera that:
Creates clear pictures so your doctor can see cancers at a very early stage
Can see lesions even in dense tissue
Provide multiple angle views
The result is quicker and more accurate detection of breast cancer than with mammography alone.
Advantages for BSGI
Can find cancers missed by mammography and ultrasound
Test right in the doctor's office
Costs less than some other imaging techniques
May help prevent the need for short term follow up for some patients.